mRNA Technology - Search News

FDA to review Moderna's mRNA flu vaccine

Scientific American · 7d

FDA won’t consider a new mRNA vaccine for flu despite the technology’s life-saving promise

The U.S. Food and Drug Administration is refusing to consider a new mRNA flu vaccine made by Moderna, the company revealed in a statement on Tuesday.

Continue reading

· 3h · on MSN

FDA Reverses Course, Will Review Moderna's mRNA Flu Vaccine

FDA agrees to review Moderna mRNA flu vaccine after initial refusal-to-file

FDA reverses course, will review Moderna's mRNA flu vaccine

Moderna said on Wednesday the U.S. Food and Drug Administration has agreed to review its influenza vaccine, reversing an earlier decision to reject the application, after the company made modification...

Continue reading

FDA Reverses Course and Will Now Review Moderna’s Flu Shot

F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine

FDA reverses surprise rejection of Moderna’s mRNA flu vaccine

“We appreciate the FDA’s engagement in a constructive Type A meeting and its agreement to advance our application for review,” Stéphane Bancel, Moderna’s CEO, said in the announcement.

Continue reading

FDA agrees to review Moderna's mRNA flu vaccine after refusal-to-file

U.S. rejection of new mRNA flu vaccine 'sends chills,' epidemiologist says